You might also like
Globe Life Inc. is an insurance holding company operating primarily in the United States, focusing on individual life and supplemental health insurance products targeted at lower middle to middle-income households . The company is organized into four main segments: life insurance, supplemental health insurance, annuities, and investments . Life insurance is the predominant segment, representing a significant portion of the total premium and underwriting margin in 2024 . Globe Life markets its products through various distribution channels, including exclusive agencies, an independent agency, and a Direct to Consumer division .
- Life Insurance - Offers traditional whole life and term life insurance products, representing the largest segment of the business and contributing significantly to the underwriting margin .
- Supplemental Health Insurance - Provides guaranteed renewable products, including Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products .
- Investments - Manages the investment portfolio and cash flow for the insurance segments and the corporate function .
- Annuities - Includes fixed-benefit contracts, which are not currently marketed as stand-alone products and represent an insignificant part of the business .
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Frank M. Svoboda ExecutiveBoard | Co-Chairman and Co-Chief Executive Officer | None | Over 36 years of insurance industry experience; previously served as CFO and President of GL subsidiaries. Expertise in tax, accounting, and capital market transactions. | |
J. Matthew Darden ExecutiveBoard | Co-Chairman and Co-Chief Executive Officer | None | Over 29 years of insurance industry experience; expertise in marketing, finance, accounting, and strategic planning. Previously served as Chief Strategy Officer and President of multiple GL subsidiaries. | |
Christopher K. Tyler Executive | Executive Vice President and Chief Information Officer | None | Technology leader with prior CIO roles at Magellan Health and Lifecare Health Partners. Joined GL in 2022. | |
Dolores L. Skarjune Executive | Executive Vice President and Chief Administrative Officer | Member of the Plan Administrative Committee. | Sales and administrative leader at GL since 2012. Promoted to EVP in 2023. Oversees Family Heritage administration. | |
Michael C. Majors Executive | Executive Vice President, Policy Acquisition and Chief Strategy Officer | None | Longtime GL executive with expertise in administration and investor relations. President of United American since 2015. | |
R. Brian Mitchell Executive | Executive Vice President, General Counsel, and Chief Risk Officer | None | Legal and risk management leader at GL since 2012. President of Liberty National and American Income subsidiaries. | |
Rebecca E. Zorn Executive | Executive Vice President and Chief Talent Officer | None | Talent management leader at GL since 2018. Oversees talent acquisition, development, and retention strategies. | |
Robert E. Hensley Executive | Executive Vice President and Chief Investment Officer | None | Investment leader with prior experience at Provident Investment Management. Joined GL in 2021. | |
Thomas P. Kalmbach Executive | Executive Vice President and Chief Financial Officer | None | Actuarial and financial leader with extensive experience at GL subsidiaries. Previously served as Chief Actuary and President of Family Heritage. | |
Alice S. Cho Board | Independent Director | Senior Advisor at Boston Consulting Group; Independent Director at First Interstate BancSystem; Member of Dean's Advisory Council at University of Chicago Harris School of Public Policy. | Financial services expert with experience in strategy and governance. | |
Cheryl D. Alston Board | Independent Director | Executive Director and CIO of Employees' Retirement Fund of Dallas; Board Member at CHRISTUS Health, Blue Cross Blue Shield of Kansas City, and Janus Henderson Mutual Fund Board. | Financial services leader with expertise in investment management and corporate governance. | |
David A. Rodriguez Board | Independent Director | Board Member at American Woodmark Corporation; Trustee at SIOP Foundation. | Former Global Chief Human Resources Officer at Marriott International with expertise in organizational culture and inclusion. | |
James P. Brannen Board | Independent Director | Board Member at First Interstate BancSystem and Amerisure Mutual Insurance Company. | Former CEO of FBL Financial Group with nearly 30 years of experience in insurance and financial services. | |
Linda L. Addison Board | Lead Director | Of Counsel at Norton Rose Fulbright US LLP; Director at Lexitas; Senior Trustee at University of Texas Law School Foundation; Board Member at Catalyst and M.D. Anderson Center Board of Visitors. | Experienced legal and governance expert with certifications in cybersecurity and climate leadership. | |
Marilyn A. Alexander Board | Independent Director | Principal at Alexander & Friedman; Director at McCarthy Holdings, Inc.; Trustee at Chapman University. | Finance and marketing expert with over 35 years of experience at Disney, Marriott, and Towers Perrin. | |
Mark A. Blinn Board | Independent Director | Director at Texas Instruments, Emerson Electric Co., and Leggett & Platt; Executive Board Member at SMU Cox Executive Board. | Former CEO and CFO of Flowserve Corporation with expertise in accounting, finance, and international business operations. | |
Mary E. Thigpen Board | Independent Director | Director at Achievelt Online, LLC; Director at Hope Bancorp, Inc. and Bank of Hope. | Technology and cybersecurity expert with experience in strategic planning and enterprise risk management. | |
Steven P. Johnson Board | Independent Director | Financial Consultant and Advisor for Boulder Creek Development, LLC. | Former Deloitte partner with expertise in accounting, auditing, and regulatory compliance. |
-
Given that mortality rates remain higher than pre-pandemic levels and you haven't returned to pre-pandemic assumptions, what specific measures are you taking to address the ongoing excess mortality, and how might this impact your future profitability?
-
With health margins under pressure due to higher claims in the Medicare supplement business and a lag in obtaining rate increases effective in 2025, how do you plan to manage the short-term profitability challenges, and what is your strategy if regulators do not approve sufficient rate increases?
-
Considering your intent to increase investments in commercial mortgage loans and limited partnerships to 25-30% of total acquisitions in 2025, how are you assessing and mitigating the risks associated with these alternative investments, especially if interest rates begin to decline?
-
Given that your 2025 guidance does not include any capital benefits from the Bermuda platform and acknowledging the time it takes to realize such benefits, can you explain the reasons for the delay in concluding this evaluation and how it aligns with your overall capital management strategy?
-
While you have seen recent improvements in life claims and margins, how sustainable do you believe these favorable trends are, and what factors could potentially reverse this improvement in the near future?
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
Evry Health | 2023 | Globe Life announced its acquisition of Evry Health in October 2023 for an immaterial amount, finalizing full ownership of a small, technology-driven healthcare start-up in major Texas urban areas to enhance customer experience and service offerings. The deal is not expected to significantly impact Globe Life's financials for 2023/2024, and its fair value estimation is still pending completion over the next year. |
Beazley Benefits (Globe Life Benefits) | 2021 | Globe Life completed the acquisition of Beazley Benefits on August 1, 2021, for $59.2 million, with the intent to broaden their reach into the worksite market via group supplemental health insurance solutions, later rebranding the unit as Globe Life Benefits. The deal included critical elements such as a 100% coinsurance agreement with a $2.5 million ceding commission and an allocation of purchase price including goodwill, distribution, and customer relationships, projecting significant health premium and underwriting income contributions in 2022. |
Recent press releases and 8-K filings for GL.
- Earnings Performance: Q1 net income reached $255 million with EPS of $3.01 (up from $2.67) and a reported ROE of 19.0%.
- Insurance Operations: Life insurance premiums increased by 3% to $830 million and health premiums by 8% to $370 million, with improved underwriting margins.
- Capital Management: The company repurchased 1.5 million shares for approximately $177 million and returned $197 million to shareholders.
- Guidance Update: Full-year net operating EPS guidance is set between $13.45 and $14.05 per diluted share, supported by favorable remeasurement gains and strategic capital allocation.